Surgery Partners files Form 144 to sell 3,657 shares

Surgery Partners, Inc. submitted a Form 144 notice relating to proposed sales of common stock, listing 3,657 shares tied to an equity vesting event dated 03/04/2026.

Rhea-AI Filing Summary

Surgery Partners, Inc. submitted a Form 144 notice relating to proposed sales of common stock, listing 3,657 shares tied to an equity vesting event dated 03/04/2026. The filing also records a reported sale of 8,785 shares on 03/06/2026 by Marissa Brittenham.

Insights

Corporate Governance Analyst

Routine Rule 144 notice for an equity compensation-related sale.

The filing lists a proposed sale of 3,657 common shares associated with an equity vesting event dated 03/04/2026. Rule 144 notices commonly precede resale by affiliates or insiders; the excerpt ties the shares to compensation vesting.

Cash‑flow treatment and the purchaser type are not disclosed in the excerpt. Subsequent SEC filings or broker reports may show whether the sale was completed and the proceeds recipient.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Surgery Partners (SGRY) Form 144 filing mean?

It notifies the SEC of an intended resale of restricted or affiliate shares. The excerpt lists 3,657 shares tied to equity vesting dated 03/04/2026, indicating a plan to sell under Rule 144 procedures.

Who sold shares in the provided SGRY excerpt?

The excerpt reports a sale by Marissa Brittenham of 8,785 shares on 03/06/2026. This line appears under "Securities Sold During The Past 3 Months."

Are the shares in the SGRY filing compensation-related?

Yes. The filing entry labels the transaction as equity vesting and equity compensation with an event date of 03/04/2026, linking the shares to a compensation vesting event.

Does the Form 144 excerpt state how proceeds will be used?

The provided excerpt does not state the use of proceeds. It lists share counts and dates but does not disclose who receives sale proceeds or their intended use.

Where were the proposed shares held for sale according to the excerpt?

The excerpt shows a broker/dealer entry of UBS Financial Services Inc with an associated figure 3,657, suggesting UBS is the listed broker for the proposed resale on 03/13/2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/13/2026 - 03:55 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001908044
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Surgery Partners, Inc.
SEC File Number	001-37576
Address of Issuer	340 Seven Springs Way, Suite 600 Brentwood TENNESSEE 37027
Phone	(615) 234-5900
Name of Person for Whose Account the Securities are To Be Sold	Marissa Brittenham
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	3657	45858.78	129419836	03/13/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
common	03/04/2026	equity vesting	Surgery Partners, Inc.			3657	03/04/2026	equity compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Marissa Brittenham 631 L St NE Washington DC 20002	common	03/06/2026	8785	120354

144: Remarks and Signature

Remarks
Date of Notice	03/13/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Mijo Suric, for UBS Financial Services Inc, as attorney-in-fact for Marissa Brittenham
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)